Clinical significance of central nervous system involvement at diagnosis of childhood t-cell acute lymphoblastic leukemia

Background Patients with T‐cell acute lymphoblastic leukemia (T‐ALL) frequently present with unfavorable features at diagnosis. Therefore, they are considered to have a higher risk to relapse. We sought to correlate initial central nervous system (CNS) disease at diagnosis with shortened survival in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric Blood & Cancer 2005-08, Vol.45 (2), p.135-138
Hauptverfasser: Jaing, Tang-Her, Yang, Chao-Ping, Hung, Iou-Jih, Tsay, Pei-Kwei, Tseng, Chen-Kan, Chen, Shih-Hsiang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 138
container_issue 2
container_start_page 135
container_title Pediatric Blood & Cancer
container_volume 45
creator Jaing, Tang-Her
Yang, Chao-Ping
Hung, Iou-Jih
Tsay, Pei-Kwei
Tseng, Chen-Kan
Chen, Shih-Hsiang
description Background Patients with T‐cell acute lymphoblastic leukemia (T‐ALL) frequently present with unfavorable features at diagnosis. Therefore, they are considered to have a higher risk to relapse. We sought to correlate initial central nervous system (CNS) disease at diagnosis with shortened survival in childhood T‐ALL. Procedure A retrospective analysis of 48 children with T‐ALL was performed. The group consisted of 32 boys and 16 girls whose median age was 8 years. Their CNS status was classified as CNS‐1 (no blast cells in cerebrospinal fluid (CSF); n = 44), CNS‐2 (
doi_str_mv 10.1002/pbc.20316
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67987994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20611976</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4576-529fc081a468a8f1b8bd5afa8af6646a261df18f53a8a067d17e5aca1502597b3</originalsourceid><addsrcrecordid>eNqFkUtP3DAQgC3UCijlwB-ofGklDgE7iR850lV5SKitKqoerYljsy5OvNjJlvz7GnYLJ9STR-NvZjz-EDqi5IQSUp6uWn1SkoryHbRPWc0KRqh48xyTZg-9S-l3RjlhchftUSZIXVK5j-aFd4PT4HFyt4OzORy0wcFibYYx5vxg4jpMCac5jabHblgHvzZ9vsUw4s7B7RCSS08lS-e7ZQgdHgttvMegp9FgP_erZWg9pNFp7M10Z3oH79FbCz6Zw-15gH6ef7lZXBbX3y6uFmfXha6Z4AUrG6uJpFBzCdLSVrYdAwsSLOc1h5LTzlJpWZVThIuOCsNAA2WkZI1oqwP0adN3FcP9ZNKoepceXweDyXspLhopmqb-L1gSTmkjeAaPN6COIaVorFpF10OcFSXqUYjKQtSTkMx-2Dad2t50L-TWQAY-bgFIWYON-f9deuF4IyjjVeZON9wf5838-kT1_fPi3-hiU-GyuIfnCoh3eedKMPXr64ViN4L8OOe1qqq_0l2yjw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20611976</pqid></control><display><type>article</type><title>Clinical significance of central nervous system involvement at diagnosis of childhood t-cell acute lymphoblastic leukemia</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Jaing, Tang-Her ; Yang, Chao-Ping ; Hung, Iou-Jih ; Tsay, Pei-Kwei ; Tseng, Chen-Kan ; Chen, Shih-Hsiang</creator><creatorcontrib>Jaing, Tang-Her ; Yang, Chao-Ping ; Hung, Iou-Jih ; Tsay, Pei-Kwei ; Tseng, Chen-Kan ; Chen, Shih-Hsiang</creatorcontrib><description>Background Patients with T‐cell acute lymphoblastic leukemia (T‐ALL) frequently present with unfavorable features at diagnosis. Therefore, they are considered to have a higher risk to relapse. We sought to correlate initial central nervous system (CNS) disease at diagnosis with shortened survival in childhood T‐ALL. Procedure A retrospective analysis of 48 children with T‐ALL was performed. The group consisted of 32 boys and 16 girls whose median age was 8 years. Their CNS status was classified as CNS‐1 (no blast cells in cerebrospinal fluid (CSF); n = 44), CNS‐2 (&lt;5 WBC/μl of CSF with blast cells; n = 0), or CNS‐3 (≥5 WBC/μl of CSF with blast cells or signs of CNS involvement; n = 4). For univariate prognostic analyses, we used the log‐rank test to determine the influence of patient characteristics (age, sex, lymphomatous presentations, initial leukocyte count, CNS disease, and newer therapeutic strategies) on each point. Results Complete remission was induced in 87.5% of patients. Median survival was 37 months, and 5‐year overall survival and disease‐free survival rates were 49.5% ± 8.1% and 47.1% ± 8.2%, respectively. Patients without initial CNS involvement seemed to have a trend toward longer overall survival (P = 0.036). Disease‐free survival was not influenced by age, leukocyte count, or other factors analyzed. Conclusions Patients who present with initial CNS involvement have a prognosis worse than that of patients without CNS disease. The introduction of early and effective CNS‐directed therapy might no longer portend a poor prognosis for CNS leukemia. © 2005 Wiley‐Liss, Inc.</description><identifier>ISSN: 1545-5009</identifier><identifier>EISSN: 1545-5017</identifier><identifier>EISSN: 1096-911X</identifier><identifier>DOI: 10.1002/pbc.20316</identifier><identifier>PMID: 15704218</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Central Nervous System Neoplasms - diagnosis ; Central Nervous System Neoplasms - mortality ; Child ; children ; Disease-Free Survival ; Female ; General aspects ; Humans ; Leukemia, T-Cell - diagnosis ; Leukemia, T-Cell - mortality ; Male ; Medical sciences ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality ; Prognosis ; prognostic factor ; Recurrence ; Retrospective Studies ; retrospective study ; Statistics, Nonparametric ; Survival Rate ; T-cell acute lymphoblastic leukemia ; Taiwan - epidemiology ; Tumors</subject><ispartof>Pediatric Blood &amp; Cancer, 2005-08, Vol.45 (2), p.135-138</ispartof><rights>Copyright © 2005 Wiley‐Liss, Inc.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4576-529fc081a468a8f1b8bd5afa8af6646a261df18f53a8a067d17e5aca1502597b3</citedby><cites>FETCH-LOGICAL-c4576-529fc081a468a8f1b8bd5afa8af6646a261df18f53a8a067d17e5aca1502597b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpbc.20316$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpbc.20316$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16971563$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15704218$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jaing, Tang-Her</creatorcontrib><creatorcontrib>Yang, Chao-Ping</creatorcontrib><creatorcontrib>Hung, Iou-Jih</creatorcontrib><creatorcontrib>Tsay, Pei-Kwei</creatorcontrib><creatorcontrib>Tseng, Chen-Kan</creatorcontrib><creatorcontrib>Chen, Shih-Hsiang</creatorcontrib><title>Clinical significance of central nervous system involvement at diagnosis of childhood t-cell acute lymphoblastic leukemia</title><title>Pediatric Blood &amp; Cancer</title><addtitle>Pediatr. Blood Cancer</addtitle><description>Background Patients with T‐cell acute lymphoblastic leukemia (T‐ALL) frequently present with unfavorable features at diagnosis. Therefore, they are considered to have a higher risk to relapse. We sought to correlate initial central nervous system (CNS) disease at diagnosis with shortened survival in childhood T‐ALL. Procedure A retrospective analysis of 48 children with T‐ALL was performed. The group consisted of 32 boys and 16 girls whose median age was 8 years. Their CNS status was classified as CNS‐1 (no blast cells in cerebrospinal fluid (CSF); n = 44), CNS‐2 (&lt;5 WBC/μl of CSF with blast cells; n = 0), or CNS‐3 (≥5 WBC/μl of CSF with blast cells or signs of CNS involvement; n = 4). For univariate prognostic analyses, we used the log‐rank test to determine the influence of patient characteristics (age, sex, lymphomatous presentations, initial leukocyte count, CNS disease, and newer therapeutic strategies) on each point. Results Complete remission was induced in 87.5% of patients. Median survival was 37 months, and 5‐year overall survival and disease‐free survival rates were 49.5% ± 8.1% and 47.1% ± 8.2%, respectively. Patients without initial CNS involvement seemed to have a trend toward longer overall survival (P = 0.036). Disease‐free survival was not influenced by age, leukocyte count, or other factors analyzed. Conclusions Patients who present with initial CNS involvement have a prognosis worse than that of patients without CNS disease. The introduction of early and effective CNS‐directed therapy might no longer portend a poor prognosis for CNS leukemia. © 2005 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Central Nervous System Neoplasms - diagnosis</subject><subject>Central Nervous System Neoplasms - mortality</subject><subject>Child</subject><subject>children</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Leukemia, T-Cell - diagnosis</subject><subject>Leukemia, T-Cell - mortality</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality</subject><subject>Prognosis</subject><subject>prognostic factor</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>retrospective study</subject><subject>Statistics, Nonparametric</subject><subject>Survival Rate</subject><subject>T-cell acute lymphoblastic leukemia</subject><subject>Taiwan - epidemiology</subject><subject>Tumors</subject><issn>1545-5009</issn><issn>1545-5017</issn><issn>1096-911X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtP3DAQgC3UCijlwB-ofGklDgE7iR850lV5SKitKqoerYljsy5OvNjJlvz7GnYLJ9STR-NvZjz-EDqi5IQSUp6uWn1SkoryHbRPWc0KRqh48xyTZg-9S-l3RjlhchftUSZIXVK5j-aFd4PT4HFyt4OzORy0wcFibYYx5vxg4jpMCac5jabHblgHvzZ9vsUw4s7B7RCSS08lS-e7ZQgdHgttvMegp9FgP_erZWg9pNFp7M10Z3oH79FbCz6Zw-15gH6ef7lZXBbX3y6uFmfXha6Z4AUrG6uJpFBzCdLSVrYdAwsSLOc1h5LTzlJpWZVThIuOCsNAA2WkZI1oqwP0adN3FcP9ZNKoepceXweDyXspLhopmqb-L1gSTmkjeAaPN6COIaVorFpF10OcFSXqUYjKQtSTkMx-2Dad2t50L-TWQAY-bgFIWYON-f9deuF4IyjjVeZON9wf5838-kT1_fPi3-hiU-GyuIfnCoh3eedKMPXr64ViN4L8OOe1qqq_0l2yjw</recordid><startdate>200508</startdate><enddate>200508</enddate><creator>Jaing, Tang-Her</creator><creator>Yang, Chao-Ping</creator><creator>Hung, Iou-Jih</creator><creator>Tsay, Pei-Kwei</creator><creator>Tseng, Chen-Kan</creator><creator>Chen, Shih-Hsiang</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200508</creationdate><title>Clinical significance of central nervous system involvement at diagnosis of childhood t-cell acute lymphoblastic leukemia</title><author>Jaing, Tang-Her ; Yang, Chao-Ping ; Hung, Iou-Jih ; Tsay, Pei-Kwei ; Tseng, Chen-Kan ; Chen, Shih-Hsiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4576-529fc081a468a8f1b8bd5afa8af6646a261df18f53a8a067d17e5aca1502597b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Biological and medical sciences</topic><topic>Central Nervous System Neoplasms - diagnosis</topic><topic>Central Nervous System Neoplasms - mortality</topic><topic>Child</topic><topic>children</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Leukemia, T-Cell - diagnosis</topic><topic>Leukemia, T-Cell - mortality</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality</topic><topic>Prognosis</topic><topic>prognostic factor</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>retrospective study</topic><topic>Statistics, Nonparametric</topic><topic>Survival Rate</topic><topic>T-cell acute lymphoblastic leukemia</topic><topic>Taiwan - epidemiology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jaing, Tang-Her</creatorcontrib><creatorcontrib>Yang, Chao-Ping</creatorcontrib><creatorcontrib>Hung, Iou-Jih</creatorcontrib><creatorcontrib>Tsay, Pei-Kwei</creatorcontrib><creatorcontrib>Tseng, Chen-Kan</creatorcontrib><creatorcontrib>Chen, Shih-Hsiang</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric Blood &amp; Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jaing, Tang-Her</au><au>Yang, Chao-Ping</au><au>Hung, Iou-Jih</au><au>Tsay, Pei-Kwei</au><au>Tseng, Chen-Kan</au><au>Chen, Shih-Hsiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical significance of central nervous system involvement at diagnosis of childhood t-cell acute lymphoblastic leukemia</atitle><jtitle>Pediatric Blood &amp; Cancer</jtitle><addtitle>Pediatr. Blood Cancer</addtitle><date>2005-08</date><risdate>2005</risdate><volume>45</volume><issue>2</issue><spage>135</spage><epage>138</epage><pages>135-138</pages><issn>1545-5009</issn><eissn>1545-5017</eissn><eissn>1096-911X</eissn><abstract>Background Patients with T‐cell acute lymphoblastic leukemia (T‐ALL) frequently present with unfavorable features at diagnosis. Therefore, they are considered to have a higher risk to relapse. We sought to correlate initial central nervous system (CNS) disease at diagnosis with shortened survival in childhood T‐ALL. Procedure A retrospective analysis of 48 children with T‐ALL was performed. The group consisted of 32 boys and 16 girls whose median age was 8 years. Their CNS status was classified as CNS‐1 (no blast cells in cerebrospinal fluid (CSF); n = 44), CNS‐2 (&lt;5 WBC/μl of CSF with blast cells; n = 0), or CNS‐3 (≥5 WBC/μl of CSF with blast cells or signs of CNS involvement; n = 4). For univariate prognostic analyses, we used the log‐rank test to determine the influence of patient characteristics (age, sex, lymphomatous presentations, initial leukocyte count, CNS disease, and newer therapeutic strategies) on each point. Results Complete remission was induced in 87.5% of patients. Median survival was 37 months, and 5‐year overall survival and disease‐free survival rates were 49.5% ± 8.1% and 47.1% ± 8.2%, respectively. Patients without initial CNS involvement seemed to have a trend toward longer overall survival (P = 0.036). Disease‐free survival was not influenced by age, leukocyte count, or other factors analyzed. Conclusions Patients who present with initial CNS involvement have a prognosis worse than that of patients without CNS disease. The introduction of early and effective CNS‐directed therapy might no longer portend a poor prognosis for CNS leukemia. © 2005 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15704218</pmid><doi>10.1002/pbc.20316</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1545-5009
ispartof Pediatric Blood & Cancer, 2005-08, Vol.45 (2), p.135-138
issn 1545-5009
1545-5017
1096-911X
language eng
recordid cdi_proquest_miscellaneous_67987994
source MEDLINE; Access via Wiley Online Library
subjects Biological and medical sciences
Central Nervous System Neoplasms - diagnosis
Central Nervous System Neoplasms - mortality
Child
children
Disease-Free Survival
Female
General aspects
Humans
Leukemia, T-Cell - diagnosis
Leukemia, T-Cell - mortality
Male
Medical sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality
Prognosis
prognostic factor
Recurrence
Retrospective Studies
retrospective study
Statistics, Nonparametric
Survival Rate
T-cell acute lymphoblastic leukemia
Taiwan - epidemiology
Tumors
title Clinical significance of central nervous system involvement at diagnosis of childhood t-cell acute lymphoblastic leukemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T10%3A01%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20significance%20of%20central%20nervous%20system%20involvement%20at%20diagnosis%20of%20childhood%20t-cell%20acute%20lymphoblastic%20leukemia&rft.jtitle=Pediatric%20Blood%20&%20Cancer&rft.au=Jaing,%20Tang-Her&rft.date=2005-08&rft.volume=45&rft.issue=2&rft.spage=135&rft.epage=138&rft.pages=135-138&rft.issn=1545-5009&rft.eissn=1545-5017&rft_id=info:doi/10.1002/pbc.20316&rft_dat=%3Cproquest_cross%3E20611976%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20611976&rft_id=info:pmid/15704218&rfr_iscdi=true